Feature Channels: AIDS and HIV

• share
• favorite_border

A new weapon to prevent HIV infection, called pre-exposure prophylaxis (PrEP), is based on the same drugs used to treat HIV-infected individuals. Thus,the big public health scare is that the dual use of these drugs will lead to skyrocketing levels of drug resistance. In fact, say UCLA researchers in a new study, that is not the case and indeed, the exact opposite is likely to happen.

• share
• favorite_border

New research from the University of North Carolina at Chapel Hill schools of medicine and pharmacy may help explain the failure of some recent clinical trials of prevention of HIV infection, compared to the success of others that used the same drugs.

• share
• favorite_border

Mayo Clinic in Florida is now offering kidney and pancreas transplants to HIV positive patients with advanced kidney disease and diabetes.

• share
• favorite_border

A study of headaches among HIV patients, which shows that HIV/AIDS patients have a 13-fold increased risk of suffering chronic migraines, is being hailed as a critical step to improving treatment and reducing unnecessary medical costs among sufferers.

• share
• favorite_border

National Association for People with AIDS (NAPWA) President and CEO Frank Oldham, Jr. Advocates for a Three Pronged Strategy to End the HIV/AIDS Epidemic: Prevention, Research to Lead to Better Treatments, and Leveling the Playing Field for Access to Healthcare and Economic Opportunity

• share
• favorite_border

A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found – a discovery that could be particularly important in rural Africa.

• share
• favorite_border

To determine why participation rates in these communities are so low, University of Toronto researchers surveyed nine focus groups comprising at-risk individuals, and found they held a set of misconceptions.

• share
• favorite_border

Experts in HIV/AIDS prevention at the University of Pennsylvania School of Nursing are available to talk with media for stories on World AIDS Day, which is on December 1.

• share
• favorite_border

Loyola HIV specialist uses Chicago example of HIV infected man who bit a cop and was charged with transmission of HIV, as an opportunity to increase education, especially with World Aids Day on Thursday, Dec. 1.

• share
• favorite_border

In this video, Douglas Richman, MD, is professor of pathology and medicine at the University of California, San Diego School of Medicine and the Florence Seeley Riford Chair in AIDS Research discusses the current status of HIV/AIDS research and what lies ahead.

• share
• favorite_border

As the world prepares to mark World AIDS Day on Dec. 1, two Florida State University professors are available to provide perspective on the fight against HIV/AIDS.

• share
• favorite_border

Dec. 1 is World AIDS Day, and in commemoration of the occasion, the HIV Vaccine Trials Network, headquartered at Fred Hutchinson Cancer Research Center, debunks the top 10 myths about HIV vaccine research.

• share
• favorite_border

A University of Cincinnati researcher from Ghana examines whether African immigrants are taking measures to protect themselves from AIDS and HIV as they adapt to living in a new country.

• share
• favorite_border

A topically applied microbicide gel containing a potent anti-HIV drug has been found to significantly reduce infection when applied to rectal tissue that was subsequently exposed to HIV in the laboratory.

• share
• favorite_border

The Children’s Hospital of Philadelphia has received funding through the Bill & Melinda Gates Foundation for research on controlling HIV infection, using a novel approach--a drug called a BET antagonist.

• share
• favorite_border

A new Supplement of the peer-reviewed journal, Women’s Health Issues, a publication of the Jacobs Institute of Women’s Health at the GW School of Public Health and Health Services, provides in-depth information about gender-specific health considerations of U.S. women and girls in the HIV/AIDS epidemic. The special Supplement, which includes recommendations for national strategic programmatic improvements to meet their needs, was sponsored by the Office on Women’s Health of the U.S. Department of Health and Human Services (HHS). Additional funding support for the Supplement was provided by the HHS Health Resources and Services Administration and the NIH National Institute on Allergy and Infectious Diseases.

• share
• favorite_border

The Infectious Disease Ambulatory Center (IDAC) at Sinai Hospital of Baltimore is a ray of hope for those who need information so they don’t contract the virus or the disease and for those who need to mange their conditions, if they are already infected.

• share
• favorite_border

Hopkins Nursing researcher Jason Farley, PhD, MPH, is at the forefront of HIV/AIDS research, leading several studies on how to protect infected patients from additional disease.

• share
• favorite_border

In a significant step toward reducing the threat of HIV, UC Merced Professor Patricia LiWang has designed what may be the most effective chemical inhibitor against infection of the virus.

• share
• favorite_border

The world's largest collection of AIDS posters is now online, providing a visual history of the first three decades of the HIV/AIDS crisis from 1981 to the present. Launched in October during the 30th anniversary year of the identification of the disease, the University of Rochester exhibit consists of more than 6,200 posters from 100 plus countries in 60 languages.